Trials / Completed
CompletedNCT00140361
Efficacy of Sulphadoxine-pyrimethamine and Artemisinin-containing Combination Therapy for Malaria
Assessing and Monitoring the Efficacy of Sulfadoxine/ Pyrimethamine (SP) and the Combination of SP Plus Artesunate for Uncomplicated Malaria Infections Among Children
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 390 (actual)
- Sponsor
- Centers for Disease Control and Prevention · Federal
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This is an ongoing monitoring activity of efficacy of sulfadoxine-pyrimethamine (SP), which is the current national treatment of choice for uncomplicated malaria in Tanzania, and a combination of SP and artesunate among children \< 5 years in 3 sites in rural Tanzania. Protocol was amended in 2004 to (1) include lumefantrine+artemether, the newly identified first-line treatment for malaria to be introduced into Tanzania in 2006; (2) on a limited basis, include adult patients; (3) extend follow-up to 28 days; (4) investigate whether treated bednets would reduce confounding by reinfection
Detailed description
This is an ongoing monitoring activity of efficacy of sulfadoxine-pyrimethamine (SP), which is the current national treatment of choice for uncomplicated malaria in Tanzania, and a combination of SP and artesunate among children \< 5 years in 3 sites in rural Tanzania. Protocol was amended in 2004 to (1) include lumefantrine+artemether, the newly identified first-line treatment for malaria to be introduced into Tanzania in 2006; (2) on a limited basis, include adult patients; (3) extend follow-up to 28 days; (4) investigate whether treated bednets would reduce confounding by reinfection
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sulfadoxine-pyrimethamine | |
| DRUG | sulfadoxine-pyrimethamine plus artesunate | |
| DRUG | lumefantrine plus artemether | |
| BEHAVIORAL | Sleeping under insecticide-treated bednet |
Timeline
- Start date
- 2000-01-01
- Primary completion
- 2008-01-01
- Completion
- 2008-01-01
- First posted
- 2005-09-01
- Last updated
- 2012-09-11
Locations
3 sites across 1 country: Tanzania
Source: ClinicalTrials.gov record NCT00140361. Inclusion in this directory is not an endorsement.